首页> 美国卫生研究院文献>Malaria Journal >Cellular engineering of Artemisia annua and Artemisia dubia with the rol ABC genes for enhanced production of potent anti-malarial drug artemisinin
【2h】

Cellular engineering of Artemisia annua and Artemisia dubia with the rol ABC genes for enhanced production of potent anti-malarial drug artemisinin

机译:利用rol ABC基因对青蒿和杜仲进行细胞工程改造以增强有效抗疟药青蒿素的产生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMalaria is causing more than half of a million deaths and 214 million clinical cases annually. Despite tremendous efforts for the control of malaria, the global morbidity and mortality have not been significantly changed in the last 50 years. Artemisinin, extracted from the medicinal plant Artemisia sp. is an effective anti-malarial drug. In 2015, elucidation of the effectiveness of artemisinin as a potent anti-malarial drug was acknowledged with a Nobel prize. Owing to the tight market and low yield of artemisinin, an economical way to increase its production is to increase its content in Artemisia sp. through different biotechnological approaches including genetic transformation.
机译:背景疟疾每年造成超过100万例死亡和2.14亿例临床病例。尽管为控制疟疾付出了巨大努力,但过去50年来全球发病率和死亡率并未发生显着变化。青蒿素,从药用植物蒿属中提取。是有效的抗疟疾药物。在2015年,阐明青蒿素作为有效的抗疟疾药物的功效获得了诺贝尔奖。由于青蒿素的市场紧缺和低产量,增加产量的一种经济方法是增加其在青蒿中的含量。通过不同的生物技术方法,包括遗传转化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号